Knowledge. Care. Connection.

Your Guide Through the ALS
Journey

Understand the science. Find practical support.
Navigate each day with greater clarity.

Evidence through 10 September 2026

US accelerated approval · Qalsody · SOD1-targeted antisense therapy
Recruiting · PREVAiLS · sigma-1 receptor agonist
Application planned · Clene · gold nanocrystal suspension
Not yet recruiting · ENDURANCE · autologous cell therapy
Not yet recruiting · AB23005 · add-on to standard care